The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Roche and Genentech have partnered withThe Weill Neurohub to accelerate the development of new therapeutics targeting brain diseases and disorders of the central nervous system (CNS). ... complex conditions to understand and treat,” said James Sabry,
Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.
business. The ancestors of these business model genera could already be seen in, for example, Roche, Mylan and Fresenius but in each case we have seen increasing specialisation and, consequently, differentiation.
The MHRA has cleared Tukysa (tucatinib) as an add-on therapy to Roche’s anti-HER2 antibody Herceptin (trastuzumb) plus Xeloda (capecitabine) for adults patients with HER2-positive locally-advanced or ... two Roche drugs given alone.
Roche’s Tecentriq (atezolizumab) was also the first checkpoint inhibitor to be approved for first-line bladder cancer therapy in patients unable to receive first-line chemotherapy in 2017.
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...